DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Goulart B, Ramsey S.
A trial-based assessment of the cost-utility of bevacizumab and chemotherapy
versus chemotherapy alone for advanced non-small cell lung cancer.
Value in Health 2011;
14: 836-845
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.